Literature DB >> 6772612

Interaction of dopamine and haloperidol with O2 and CO2 chemoreception in carotid body.

S Lahiri, T Nishino, A Mokashi, E Mulligan.   

Abstract

Effects of dopamine and of a dopaminergic blocker, haloperidol, on the responses of carotid body chemoreceptors to hypoxia and hypercapnia were investigated in 16 anesthetized cats. Intravenous infusion of dopamine (10-20 micrograms.min-1) decreased carotid body chemoreceptor responses to hypoxia and hypercapnia. The effect was greater at higher levels of arterial oxygen and carbon dioxide tension (PaO2 and PaCO2) stimulus. Thus, the magnitude of the dopamine effect depended on the degree of both PO2- and PCO2-mediated excitation of the receptors. Haloperidol potentiated responses to both hypoxia and hypercapnia but apparently did not stimulate the receptors in the absence of these stimuli. Potentiation by haloperidol and inhibition by dopamine of excitatory effects due to PaO2 decrease and PaCO2 increase are complementary. The data suggest that chemoreception of dopamine, O2, and CO2 converge at some site in the carotid body. Persistence of hypoxic and hypercapnic responses, following dopamine-blocking doses of haloperidol, does not support the theory that regulation of dopamine release is responsible for O2 and CO2 chemoreception in carotid body of the cat.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6772612     DOI: 10.1152/jappl.1980.49.1.45

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  11 in total

Review 1.  The ventilatory responsiveness to CO(2) below eupnoea as a determinant of ventilatory stability in sleep.

Authors:  Jerome A Dempsey; Curtis A Smith; Tadeuez Przybylowski; Bruno Chenuel; Ailiang Xie; Hideaki Nakayama; James B Skatrud
Journal:  J Physiol       Date:  2004-07-29       Impact factor: 5.182

2.  Effect of exogenous dopamine on the hypercapnic ventilatory response in cats during normoxia.

Authors:  A Berkenbosch; J DeGoede; C N Olievier; D S Ward
Journal:  Pflugers Arch       Date:  1986-11       Impact factor: 3.657

3.  The distribution and ultrastructure of sensory elements in the baroreceptor region of the truncus arteriosus of the lizard Trachydosaurus rugosus.

Authors:  P J Berger; I L Gibbins; D K Hards; L J Crosby
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

4.  The carotid chemoreceptor contributes to the elevated arterial stiffness and vasoconstrictor outflow in chronic obstructive pulmonary disease.

Authors:  Devin B Phillips; Craig D Steinback; Sophie É Collins; Desi P Fuhr; Tracey L Bryan; Eric Y L Wong; Vincent Tedjasaputra; Mohit Bhutani; Michael K Stickland
Journal:  J Physiol       Date:  2018-04-11       Impact factor: 5.182

5.  Interactions between hypoxia, acetylcholine and dopamine in the carotid body of rabbit and cat.

Authors:  J Ponte; C L Sadler
Journal:  J Physiol       Date:  1989-03       Impact factor: 5.182

6.  Carotid chemoreceptor modulation of blood flow during exercise in healthy humans.

Authors:  Michael K Stickland; Desi P Fuhr; Mark J Haykowsky; Kelvin E Jones; D Ian Paterson; Justin A Ezekowitz; M Sean McMurtry
Journal:  J Physiol       Date:  2011-10-24       Impact factor: 5.182

7.  Effects of apomorphine and haloperidol in fetal lambs.

Authors:  O S Bamford; G S Dawes; R A Ward
Journal:  J Physiol       Date:  1986-08       Impact factor: 5.182

8.  Effects of the dopamine antagonists haloperidol and domperidone on the normoxic ventilatory response to CO2 in cats.

Authors:  A Berkenbosch; C N Olievier; J DeGoede
Journal:  Pflugers Arch       Date:  1988-03       Impact factor: 3.657

9.  Developmental changes in hypoxia-induced catecholamine release from rat carotid body, in vitro.

Authors:  D F Donnelly; T P Doyle
Journal:  J Physiol       Date:  1994-03-01       Impact factor: 5.182

10.  Adrenergic mechanisms and chemoreception in the carotid body of the cat and rabbit.

Authors:  H Folgering; J Ponte; T Sadig
Journal:  J Physiol       Date:  1982-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.